BONNIE DANIEL: Open Payments
NPI 1235715962 · NEOSHO, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,987 in 131 payments from 22 companies in 2025. Trend: 2023 $831 · 2024 $1,836 · 2025 $1,987
Food & beverage: $1,987
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $427 |
| AstraZeneca Pharmaceuticals LP | 12 | $264 |
| Amgen Inc. | 19 | $176 |
| Novo Nordisk Inc | 11 | $165 |
| PFIZER INC. | 13 | $145 |
| Otsuka America Pharmaceutical, Inc. | 9 | $139 |
| GlaxoSmithKline, LLC. | 5 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| Lilly USA, LLC | 3 | $63 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $59 |
Products named: VRAYLAR, BREZTRI, NURTEC ODT, REXULTI, Ozempic, OTEZLA, TRELEGY ELLIPTA, CAPLYTA.
Industry payments across MO — which companies pay providers there.
